176 related articles for article (PubMed ID: 24988984)
21. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
[TBL] [Abstract][Full Text] [Related]
22. Comparison of genetic polymorphisms of CYP2E1, ADH2, and ALDH2 genes involved in alcohol metabolism in Koreans and four other ethnic groups.
Kang TS; Woo SW; Park HJ; Lee Y; Roh J
J Clin Pharm Ther; 2009 Apr; 34(2):225-30. PubMed ID: 19250143
[TBL] [Abstract][Full Text] [Related]
23. Unraveling CYP2E1 haplotypes in alcoholics from Central Brazil: A comparative study with 1000 genomes population.
Ramos JSA; Felício LP; Alves AA; Lopes MP; Soares TN; de Melo E Silva D
Environ Toxicol Pharmacol; 2018 Sep; 62():30-39. PubMed ID: 29940492
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel allelic variant of CYP2C8, CYP2C8*11, in Asian populations and its clinical effect on the rosiglitazone disposition in vivo.
Yeo CW; Lee SJ; Lee SS; Bae SK; Kim EY; Shon JH; Rhee BD; Shin JG
Drug Metab Dispos; 2011 Apr; 39(4):711-6. PubMed ID: 21245287
[TBL] [Abstract][Full Text] [Related]
25. Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub-Saharan African Populations.
Twesigomwe D; Drögemöller BI; Wright GEB; Adebamowo C; Agongo G; Boua PR; Matshaba M; Paximadis M; Ramsay M; Simo G; Simuunza MC; Tiemessen CT; Lombard Z; Hazelhurst S
Clin Pharmacol Ther; 2024 Mar; 115(3):576-594. PubMed ID: 38049200
[TBL] [Abstract][Full Text] [Related]
26. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
[TBL] [Abstract][Full Text] [Related]
27. The influence of cytochrome oxidase CYP2A6, CYP2B6, and CYP2C9 polymorphisms on the plasma concentrations of valproic acid in epileptic patients.
Tan L; Yu JT; Sun YP; Ou JR; Song JH; Yu Y
Clin Neurol Neurosurg; 2010 May; 112(4):320-3. PubMed ID: 20089352
[TBL] [Abstract][Full Text] [Related]
28. CYP2A6 polymorphism reveals differences in Japan and the existence of a specific variant in Ovambo and Turk populations.
Takeshita H; Hieda Y; Fujihara J; Xue Y; Nakagami N; Takayama K; Imamura S; Kataoka K
Hum Biol; 2006 Apr; 78(2):235-42. PubMed ID: 17036930
[TBL] [Abstract][Full Text] [Related]
29. Global variation in CYP2C8-CYP2C9 functional haplotypes.
Speed WC; Kang SP; Tuck DP; Harris LN; Kidd KK
Pharmacogenomics J; 2009 Aug; 9(4):283-90. PubMed ID: 19381162
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
[TBL] [Abstract][Full Text] [Related]
31. Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients.
Elens L; Vandercam B; Yombi JC; Lison D; Wallemacq P; Haufroid V
Pharmacogenomics; 2010 Sep; 11(9):1223-34. PubMed ID: 20860463
[TBL] [Abstract][Full Text] [Related]
32. CYP2B6 non-coding variation associated with smoking cessation is also associated with differences in allelic expression, splicing, and nicotine metabolism independent of common amino-acid changes.
Bloom AJ; Martinez M; Chen LS; Bierut LJ; Murphy SE; Goate A
PLoS One; 2013; 8(11):e79700. PubMed ID: 24260284
[TBL] [Abstract][Full Text] [Related]
33. Screening for SNPs and haplotypes in the CYP3A7 gene in Chinese populations.
Du J; Shi Y; Zhang A; Wang L; Xuan J; He G; Xu L; Xu M; Shu A; Yu L; Li X; Meng J; Feng G; Xing Q; He L
Pharmacogenomics; 2007 Jun; 8(6):559-66. PubMed ID: 17559345
[TBL] [Abstract][Full Text] [Related]
34. Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.
Lamba V; Lamba J; Yasuda K; Strom S; Davila J; Hancock ML; Fackenthal JD; Rogan PK; Ring B; Wrighton SA; Schuetz EG
J Pharmacol Exp Ther; 2003 Dec; 307(3):906-22. PubMed ID: 14551287
[TBL] [Abstract][Full Text] [Related]
35. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.
Tsukino H; Kuroda Y; Qiu D; Nakao H; Imai H; Katoh T
Int J Cancer; 2002 Aug; 100(4):425-8. PubMed ID: 12115524
[TBL] [Abstract][Full Text] [Related]
36. Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis.
Kaspera R; Naraharisetti SB; Tamraz B; Sahele T; Cheesman MJ; Kwok PY; Marciante K; Heckbert SR; Psaty BM; Totah RA
Pharmacogenet Genomics; 2010 Oct; 20(10):619-29. PubMed ID: 20739906
[TBL] [Abstract][Full Text] [Related]
37. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.
Zanger UM; Klein K; Saussele T; Blievernicht J; Hofmann MH; Schwab M
Pharmacogenomics; 2007 Jul; 8(7):743-59. PubMed ID: 17638512
[TBL] [Abstract][Full Text] [Related]
38. Haplotype structure and allele frequencies of CYP2B6 in a Korean population.
Cho JY; Lim HS; Chung JY; Yu KS; Kim JR; Shin SG; Jang IJ
Drug Metab Dispos; 2004 Dec; 32(12):1341-4. PubMed ID: 15383491
[TBL] [Abstract][Full Text] [Related]
39. Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.
García-Martín E; Martínez C; Ladero JM; Agúndez JA
Mol Diagn Ther; 2006; 10(1):29-40. PubMed ID: 16646575
[TBL] [Abstract][Full Text] [Related]
40. Intra- and inter-ethnic differences in the allele frequencies of cytochrome P450 2B6 gene in Chinese.
Guan S; Huang M; Li X; Chen X; Chan E; Zhou SF
Pharm Res; 2006 Sep; 23(9):1983-90. PubMed ID: 16951995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
